Management of the seronegative spondyloarthropathies.
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D001168:Arthritis / Q000628:therapy; D016918:Arthritis, Reactive / Q000188:drug therapy; D005598:Fractures, Spontaneous / Q000601:surgery; D006622:Hip Prosthesis; D006801:Humans; D008727:Methotrexate / Q000627:therapeutic use; D010027:Osteotomy; D026741:Physical Therapy Modalities; D011565:Psoriasis / Q000628:therapy; D013166:Spondylitis / Q000534:rehabilitation / Q000628:therapy*; D013167:Spondylitis, Ankylosing / Q000150:complications / Q000534:rehabilitation / Q000628:therapy
D000305:Adrenal Cortex Hormones; D000893:Anti-Inflammatory Agents; D008727:Methotrexate